Cornman, Hannah L.
Manjunath, Jaya
Reddy, Sriya V.
Adams, Jackson
Rajeh, Ahmad
Samuel, Christeen
Bao, Aaron
Zhao, Ryan
Ma, Emily Z.
Shumsky, Jason
Pritchard, Thomas W.
Imo, Brenda Umenita
Kollhoff, Alexander L.
Lee, Kevin K.
Lu, Weiying
Yossef, Selina
Kwatra, Madan M.
Kwatra, Shawn G.
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (K23AR077073)
Article History
Received: 27 November 2023
Accepted: 25 March 2024
First Online: 6 April 2024
Competing interests
: Dr. Kwatra is an advisory board member/consultant for Abbvie, Aslan Pharmaceuticals, Arcutis Biotherapeutics, Castle Biosciences, Celldex Therapeutics, Galderma, Genzada Pharmaceuticals, Incyte Corporation, Johnson & Johnson, Leo Pharma, Novartis Pharmaceuticals Corporation, Pfizer, Regeneron Pharmaceuticals, and Sanofi and has served as an investigator for Galderma, Incyte, Pfizer, and Sanofi. All other authors report no conflicts of interest.